Literature DB >> 15820221

Overexpression of manganese superoxide dismutase protects against ATP depletion-mediated cell death of proximal tubule cells.

Danielle L Cruthirds1, Hamida Saba, Lee Ann MacMillan-Crow.   

Abstract

We have previously shown that in vivo renal ischemia/reperfusion results in ATP depletion, oxidant production, and manganese superoxide dismutase (MnSOD) inactivation. Current studies were designed to compare the effect of ATP depletion (Antimycin A treatment) on cell death pathways using renal proximal tubular cells and identical cells that overexpress MnSOD. ATP depletion in wild-type cells induced an apoptotic cascade that involved caspase 9 activation; MnSOD overexpressing cells afforded protection against apoptosis. This protection did not appear to involve a cytochrome c-related mechanism, but may be related to altered levels of nitric oxide within the cell. Further studies suggested that nitric oxide was required to protect the renal cells from caspase-mediated cell death. Interestingly, treatment of renal cell extracts with reductants (DTT and ascorbate) enhanced caspase activation. Taken together, these results suggest that cysteine nitrosylation may be playing a role in caspase dysfunction in cells overexpressing MnSOD following ATP depletion.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15820221     DOI: 10.1016/j.abb.2005.02.023

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  14 in total

1.  SOD1 and MitoTEMPO partially prevent mitochondrial permeability transition pore opening, necrosis, and mitochondrial apoptosis after ATP depletion recovery.

Authors:  Huan Ling Liang; Filip Sedlic; Zeljko Bosnjak; Vani Nilakantan
Journal:  Free Radic Biol Med       Date:  2010-08-22       Impact factor: 7.376

2.  In vitro model of sepsis-induced renal epithelial reactive nitrogen species generation.

Authors:  Elina Pathak; Philip R Mayeux
Journal:  Toxicol Sci       Date:  2010-02-22       Impact factor: 4.849

Review 3.  Purinergic signalling in the kidney in health and disease.

Authors:  Geoffrey Burnstock; Louise C Evans; Matthew A Bailey
Journal:  Purinergic Signal       Date:  2013-11-22       Impact factor: 3.765

4.  Role of mitochondrial-derived oxidants in renal tubular cell cold-storage injury.

Authors:  Tanecia Mitchell; Hamida Saba; Joe Laakman; Nirmala Parajuli; Lee Ann MacMillan-Crow
Journal:  Free Radic Biol Med       Date:  2010-07-24       Impact factor: 7.376

5.  Hyperglycaemia and diabetes impair gap junctional communication among astrocytes.

Authors:  Gautam K Gandhi; Kelly K Ball; Nancy F Cruz; Gerald A Dienel
Journal:  ASN Neuro       Date:  2010-03-15       Impact factor: 4.146

6.  Astrocytic gap junctional communication is reduced in amyloid-β-treated cultured astrocytes, but not in Alzheimer's disease transgenic mice.

Authors:  Nancy F Cruz; Kelly K Ball; Gerald A Dienel
Journal:  ASN Neuro       Date:  2010-08-17       Impact factor: 4.146

7.  Differential patterns of peroxynitrite mediated apoptosis in proximal tubular epithelial cells following ATP depletion recovery.

Authors:  Vani Nilakantan; Huanling Liang; Cheryl J Maenpaa; Christopher P Johnson
Journal:  Apoptosis       Date:  2008-05       Impact factor: 4.677

Review 8.  Oxidative stress in hypertension: role of the kidney.

Authors:  Magali Araujo; Christopher S Wilcox
Journal:  Antioxid Redox Signal       Date:  2013-04-30       Impact factor: 8.401

9.  Favorable balance of anti-oxidant/pro-oxidant systems and ablated oxidative stress in Brown Norway rats in renal ischemia-reperfusion injury.

Authors:  Vani Nilakantan; Gail Hilton; Cheryl Maenpaa; Scott K Van Why; Galen M Pieper; Christopher P Johnson; Brian D Shames
Journal:  Mol Cell Biochem       Date:  2007-04-26       Impact factor: 3.396

Review 10.  Novel pharmacological approaches to the treatment of renal ischemia-reperfusion injury: a comprehensive review.

Authors:  Prabal K Chatterjee
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-09-22       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.